BetterLife Announces Closing of Private Placement
07 déc. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has...
BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona
02 déc. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Axiom Medical Hosts ALL THE RIGHT MOVES: A virtual Summit modernizing workplace mental health education and accessibility Thursday November 3, 2022
28 oct. 2022 15h29 HE
|
Axiom Medical
The Woodlands, TX, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Join host Holly Foxworth, RN for a dynamic, half-day virtual mental health summit, featuring seven (7) fastbreak sessions and panel discussions...
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
27 sept. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Ovia Health Recognized by HHS for Program to Improve Birth Equity
13 sept. 2022 09h00 HE
|
Ovia Health
Company Extends Focus on Underserved Patients Named a Phase 1 Winner in the HHS Racial Equity and Postpartum Care Challenge BOSTON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Ovia Health, the most...
BetterLife and Collaborators to Submit Key Joint Research Publication
07 sept. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects
24 août 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), is an emerging biotech company focused...
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies
06 juil. 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference
23 juin 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum
21 juin 2022 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...